Contraindicated in:
Use Cautiously in:
CV: edema, chest pain, hypertension.
Derm: rash.
Endo: menstrual disorders, hyperthyroidism, hypothyroidism, menorrhagia.
GI: abdominal pain, constipation, nausea, vomiting, autoimmune hepatitis, ↑ liver enzymes.
GU: urgency, erectile dysfunction, spontaneous abortion.
Hemat: neutropenia, anemia, HEMOLYTIC UREMIC SYNDROME, thrombocytopenia, THROMBOTIC THROMBOCYTOPENIC PURPURA.
Local: injection-site reactions , injection site necrosis.
MS: myalgia, pain, muscle spasm.
Neuro: depression, headache, incoordination, insomnia, suicidal thoughts.
Resp: dyspnea.
Misc: chills, fever, flu-like symptoms, drug-induced lupus erythematosus, HYPERSENSITIVITY REACTIONS(INCLUDING ANAPHYLAXIS) .
Therapeutic Classification: anti-multiple sclerosis agents, immune modifiers
Pharmacologic Classification: interferons
Absorption: 50% absorbed following subcutaneous administration.
Distribution: Unknown.
Metabolism/Excretion: Unknown.
Half-life: 8 min4.3 hr.
NDC Code*